SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : Pharmos(PARS)
PARS 2.700+13.6%Jan 21 4:00 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Zvi Steinberg who wrote (1236)9/13/1998 9:38:00 PM
From: erin4   of 1491
 
To Wilemspal, I do own alot of Pars at a higher price as do most of us. I plan to acquire more as upward momentum appears and the clinical tests results are revealed. Keep in mind that HU211 if it is a hit is still several years away from the market and from making any money for Pharmos. There is the possibility that with very positive results it could be put on accelerated FDA approval because there is nothing quite like it on the market currently and there is a tremendous need to halt brain cell death after trauma or stroke etc.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News